Abbi N Simons1, Christopher J Moreland2, Poorna Kushalnagar3. 1. Department of Science, Technology, and Mathematics, Gallaudet University, Washington, District of Columbia, USA. 2. University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA. 3. Department of Psychology, Gallaudet University, Washington, District of Columbia, USA.
Abstract
BACKGROUND: In the United States, roughly one-third of adults have hypertension; another third have prehypertension. The prevalence of hypertension in deaf American Sign Language (ASL) users is unknown. We address this gap through a descriptive study for the prevalence of hypertension in the American Deaf community and discuss future directions to address this issue. METHODS: Self-reported data for 1,388 ASL using deaf adults were compared with a secondary data of 2,830 English-speaking hearing adults. Frequency and percentages were used to describe the prevalence of hypertension in the deaf community. Age-weighted analysis was used to compare unmodifiable risk factors and hypertension rate between deaf and hearing adults. RESULTS: Deaf and hearing samples' hypertension rates for gender and age were similar. Significant group differences between deaf and hearing samples emerged across race. Compared with the hearing controls, our deaf sample demonstrated a significantly decreased risk for hypertension with a prevalence of 37% (compared with 45% in the hearing sample). CONCLUSIONS: Although the hypertension rate for gender and age was similar across deaf and hearing samples, between-group disparities exist for race. The lower rate of hypertension in our deaf sample is likely a consequence of underdiagnoses due to lower health literacy and poor patient-physician communication. Furthermore, deaf black Americans' lower rates compared with hearing black Americans may be due to poor patient-physician communication, not having regular providers or social stressors. It is recommended that modifiable risk factors and social determinants be investigated to determine their effect on hypertension within the deaf community.
BACKGROUND: In the United States, roughly one-third of adults have hypertension; another third have prehypertension. The prevalence of hypertension in deaf American Sign Language (ASL) users is unknown. We address this gap through a descriptive study for the prevalence of hypertension in the American Deaf community and discuss future directions to address this issue. METHODS: Self-reported data for 1,388 ASL using deaf adults were compared with a secondary data of 2,830 English-speaking hearing adults. Frequency and percentages were used to describe the prevalence of hypertension in the deaf community. Age-weighted analysis was used to compare unmodifiable risk factors and hypertension rate between deaf and hearing adults. RESULTS: Deaf and hearing samples' hypertension rates for gender and age were similar. Significant group differences between deaf and hearing samples emerged across race. Compared with the hearing controls, our deaf sample demonstrated a significantly decreased risk for hypertension with a prevalence of 37% (compared with 45% in the hearing sample). CONCLUSIONS: Although the hypertension rate for gender and age was similar across deaf and hearing samples, between-group disparities exist for race. The lower rate of hypertension in our deaf sample is likely a consequence of underdiagnoses due to lower health literacy and poor patient-physician communication. Furthermore, deaf black Americans' lower rates compared with hearing black Americans may be due to poor patient-physician communication, not having regular providers or social stressors. It is recommended that modifiable risk factors and social determinants be investigated to determine their effect on hypertension within the deaf community.
Authors: Paul D Sorlie; Matthew A Allison; M Larissa Avilés-Santa; Jianwen Cai; Martha L Daviglus; Annie G Howard; Robert Kaplan; Lisa M Lavange; Leopoldo Raij; Neil Schneiderman; Sylvia Wassertheil-Smoller; Gregory A Talavera Journal: Am J Hypertens Date: 2014-03-12 Impact factor: 2.689
Authors: Gaurav J Dave; Daniel L Bibeau; Mark R Schulz; Robert E Aronson; Louise L Ivanov; Adina Black; Lapronda Spann Journal: J Clin Hypertens (Greenwich) Date: 2013-05-09 Impact factor: 3.738
Authors: Michel Joffres; Emanuela Falaschetti; Cathleen Gillespie; Cynthia Robitaille; Fleetwood Loustalot; Neil Poulter; Finlay A McAlister; Helen Johansen; Oliver Baclic; Norm Campbell Journal: BMJ Open Date: 2013-08-30 Impact factor: 2.692